NCT02315872 - ACTH for Fatigue in Multiple Sclerosis Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 22, 2015

Primary Completion Date

June 20, 2017

Study Completion Date

December 13, 2018

Conditions

Multiple Sclerosis, Relapsing-Remitting

Interventions

DRUG

ACTH

ACTH injections twice weekly for 28 weeks.

DRUG

Placebo

Placebo injections twice weekly for 28 weeks.

Trial Locations (5)

North Central Neurology Associates, PC, Cullman

Providence St. Vincent Medical Center, Portland

Providence Medical Group - Medford Neurology, Medford

Swedish Medical Center, Seattle

MultiCare Health System -- Institute for Research and Innovation, Tacoma